Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

Matthew Farrer, Canada Excellence Research Chair (CERC) in Neurogenetics and Translational Neuroscience, University of British Columbia, Vancouver.

Martin Dee

The thirst for top researchers has resulted in both the Canada Research Chair, which provides up to $300-million a year for 2,000 chairholders in a variety of disciplines, and the Canada Excellence Research Chair, under which CERCs are granted up to $10-million over seven years to establish research programs. These programs help institutions to attract top international talent and can help them gain an academic edge. Chairholders say the grants give them much-needed time to spend researching their chosen fields and means less time buried in paperwork, applying for grants.

Here are three leading researchers from across the country:

Matthew Farrer

Story continues below advertisement

Canada Excellence Research Chair (CERC) in Neurogenetics and Translational Neuroscience, University of British Columbia, Vancouver.

Matthew Farrer's passion for his research into Parkinson's disease is obvious when he talks about some of his latest studies into the affliction – how a late-onset form of the disease is affecting a large Mennonite family in Saskatoon.

He received old photographs from the family, which has been suffering from the disease, going back generations.

"There is one, it is a very sad picture. It is these seven brothers and they range in age from a year-and-a-half to nine or 10 years, lined up against this barn. It's an old sepia photograph from the 1920s." All the brothers but one eventually died of Parkinson's, he said.

With the help of the family, Dr. Farrer and his team at UBC Medical Genetics identified the mutation in the gene (DNAJC13) associated with typical late-onset Lewy body Parkinson's disease in 2012. Dr. Farrer is grateful to the relatives, who gave blood samples and clinical information in order for the group to map the genes responsible for the disease.

"They've given this gift of DNA clinical information for someone like me to try and understand the condition. It's a humanitarian gift because chances are that anyone in the family who's got the disease right now is actually going to benefit are very slim." Twelve of 57 members of the family who participated have been diagnosed with Parkinson's.

Dr. Farrer came to UBC from the Mayo Clinic in Jacksonville, Fla., where he had established an independent lab in molecular neuroscience. He was attracted to UBC because of its brain research centre and high-calibre imaging program. Once there, he established the Centre for Applied Neurogenetics, a global consortium of scientists studying molecular origins of brain diseases. That team is credited with having identified most of the mutant genes responsible for late-onset Parkinson's. Ultimately, he would like to help find tools that the pharmaceutical community can use to create drugs to slow the progression of neurodegenerative diseases and to find new strategies for early detection. If the drugs can be taken early enough, they can prevent the disease altogether, he says. "I made a promise to the field and to the patients and to the families years ago that we are going to do something useful with the DNA that we get. We are going to push this envelope as far as we can to deliver on the promise."

Story continues below advertisement

Susanne Lajoie

Canada Research Chair, Advanced Technologies for Learning in Authentic Settings, McGill University, Montreal

As an educational psychology student at California's Stanford University, Susanne Lajoie studied learning differences between psychology and engineering majors. Psych majors were high verbal learners, while engineering majors were high spatial learners. The spatial learners were more efficient, she says.

"I looked at the differences between the individuals and thought, 'Wouldn't it be neat to teach those that don't have these strategies a way to solve these problems?' " Her research spurred her to design "tutoring systems," to help neophytes practice real-world technology and gain experience. She later helped a University of Pittsburgh professor create an avionics tutor for F-15 airmen to troubleshoot when something went wrong on the aircraft. After two weeks of training on the system, novices were able to perform as well as those who had been on the job four years, she says.

Fast forward several decades, and Dr. Lajoie is currently a Canada Research Chair at McGill, studying ways to use technology to improve the quality of teaching and learning in science and medicine.

Technology is a powerful tool, she says. "Technology allows you to build these interesting, more immersive environments so that people feel that they are doing something that is similar to what they would be doing in the real world."

Story continues below advertisement

At McGill, Dr. Lajoie's current focus is looking at how medical students learn using computer simulations that mimic what they will encounter in the field. Her "Bioworld" system allows students to help solve patient cases. Students check on patients, interpret symptoms and conduct diagnostic tests. The goal, Dr. Lajoie says, isn't to come to the correct solution – lots of students are able to do that – but to observe how they are learning and their thought processes. "What are the things that they do to reach the solution that reflect more of the deeper knowledge that we want them to be focused on. Do they become more expert-like in their problem-solving activities?"

Dr. Lajoie says her learning systems can be applied to any discipline, not just medicine. She enjoys her work immensely. "We can support learners to learn better and with deeper understanding in exciting ways. "

Soren Rysgaard

Canada Excellence Research Chair in Arctic Geomicrobiology and Climate Change, University of Manitoba, Winnipeg

Sea ice is melting in the Arctic at an alarming rate – and the study of this ice may be the key to discovering the region's role in climate change.

To look deeper into this problem, the University of Manitoba has launched a $35-million research program and facility to study climate change, headed by its new CERC, Soren Rysgaard. Part of the funding has resulted in the opening of a specialized floor in the science building for classrooms and labs, along with outdoor tanks in which to grow and study sea ice.

Story continues below advertisement

Dr. Rysgaard's love of the North comes naturally. A native of Denmark, he got his first taste while doing a biogeochemistry lab on a trip to the far North, looking at how biology plays a role in chemical reactions. After that, he was hooked.

Dr. Rysgaard is now one of the world's experts in geomicrobiology, which is the study of the role of minerals in microbial processes and microbes in geological processes. Traditionally, he says, it was thought that nothing much was happening within the microbial layers of sea ice high in the North. But it's now known that this ice is teeming with tubes and channels, which are home for micro-organisms and chemical reactions.

"We are trying to understand how all this is related to sea ice and how can these tiny things regulate stuff on a much larger scale." For example, he says, algae in sea ice may actually control how ice is growing. Another part of his studies of the ice on a micro scale is to looks at sea ice's relation to the greenhouse gas carbon dioxide. His research suggests sea ice is key to removing carbon dioxide from the atmosphereand he is looking at what impact that will have on the rate of climate change if sea ice disappears.

Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies